Kopran Ltd. is an integrated Pharmaceutical Company, committed to manufacture and supply International Quality Formulations and Active Pharmaceutical Ingredients worldwide.
Financial Results:
- Kopran Ltd reported Revenues for Q1FY24 of ₹117.00 Crores down from ₹125.62 Crore year on year, a fall of 6.86%.
- Total Expenses for Q1FY24 of ₹115.78 Crores down from ₹116.30 Crores year on year, a fall of 0.45%.
- Consolidated Net Profit of ₹2.77 Crores down 63.55% from ₹7.60 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹0.57, down 63.92% from ₹1.58 in the same quarter of the previous year.